ETIHX vs. ETILX
Compare and contrast key facts about Eventide Healthcare & Life Sciences Fund (ETIHX) and Eventide Gilead Class I (ETILX).
ETIHX is managed by Eventide Funds. It was launched on Dec 26, 2012. ETILX is managed by Eventide Funds.
Performance
ETIHX vs. ETILX - Performance Comparison
Loading graphics...
ETIHX vs. ETILX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ETIHX Eventide Healthcare & Life Sciences Fund | -4.72% | 56.73% | -10.13% | 11.01% | -19.62% | -16.87% | 37.12% | 58.74% | -0.27% | 45.83% |
ETILX Eventide Gilead Class I | -6.85% | 23.77% | -0.03% | 22.76% | -34.03% | 11.44% | 55.44% | 34.11% | -2.35% | 33.09% |
Returns By Period
In the year-to-date period, ETIHX achieves a -4.72% return, which is significantly higher than ETILX's -6.85% return. Over the past 10 years, ETIHX has outperformed ETILX with an annualized return of 12.95%, while ETILX has yielded a comparatively lower 11.91% annualized return.
ETIHX
- 1D
- 6.18%
- 1M
- -2.47%
- YTD
- -4.72%
- 6M
- 20.62%
- 1Y
- 66.40%
- 3Y*
- 14.82%
- 5Y*
- 1.31%
- 10Y*
- 12.95%
ETILX
- 1D
- 4.16%
- 1M
- -6.72%
- YTD
- -6.85%
- 6M
- -2.01%
- 1Y
- 25.57%
- 3Y*
- 9.19%
- 5Y*
- 0.47%
- 10Y*
- 11.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
ETIHX vs. ETILX - Expense Ratio Comparison
ETIHX has a 1.30% expense ratio, which is higher than ETILX's 1.11% expense ratio.
Return for Risk
ETIHX vs. ETILX — Risk / Return Rank
ETIHX
ETILX
ETIHX vs. ETILX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eventide Healthcare & Life Sciences Fund (ETIHX) and Eventide Gilead Class I (ETILX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETIHX | ETILX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.33 | 1.13 | +1.20 |
Sortino ratioReturn per unit of downside risk | 3.06 | 1.67 | +1.39 |
Omega ratioGain probability vs. loss probability | 1.39 | 1.23 | +0.16 |
Calmar ratioReturn relative to maximum drawdown | 4.26 | 1.69 | +2.57 |
Martin ratioReturn relative to average drawdown | 14.67 | 6.67 | +8.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ETIHX | ETILX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.33 | 1.13 | +1.20 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | 0.02 | +0.03 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.46 | 0.51 | -0.05 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.54 | -0.02 |
Correlation
The correlation between ETIHX and ETILX is 0.78, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
ETIHX vs. ETILX - Dividend Comparison
ETIHX has not paid dividends to shareholders, while ETILX's dividend yield for the trailing twelve months is around 12.95%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ETIHX Eventide Healthcare & Life Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.78% | 3.49% | 2.08% | 7.33% | 1.28% | 0.00% | 1.22% |
ETILX Eventide Gilead Class I | 12.95% | 12.07% | 1.25% | 0.00% | 5.36% | 6.30% | 0.79% | 3.14% | 5.31% | 0.00% | 0.00% | 1.13% |
Drawdowns
ETIHX vs. ETILX - Drawdown Comparison
The maximum ETIHX drawdown since its inception was -55.11%, which is greater than ETILX's maximum drawdown of -41.30%. Use the drawdown chart below to compare losses from any high point for ETIHX and ETILX.
Loading graphics...
Drawdown Indicators
| ETIHX | ETILX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.11% | -41.30% | -13.81% |
Max Drawdown (1Y)Largest decline over 1 year | -12.50% | -14.40% | +1.90% |
Max Drawdown (5Y)Largest decline over 5 years | -49.49% | -41.30% | -8.19% |
Max Drawdown (10Y)Largest decline over 10 years | -55.11% | -41.30% | -13.81% |
Current DrawdownCurrent decline from peak | -7.09% | -13.49% | +6.40% |
Average DrawdownAverage peak-to-trough decline | -18.17% | -11.60% | -6.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.79% | 3.66% | +0.13% |
Volatility
ETIHX vs. ETILX - Volatility Comparison
Eventide Healthcare & Life Sciences Fund (ETIHX) has a higher volatility of 10.04% compared to Eventide Gilead Class I (ETILX) at 8.27%. This indicates that ETIHX's price experiences larger fluctuations and is considered to be riskier than ETILX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ETIHX | ETILX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.04% | 8.27% | +1.77% |
Volatility (6M)Calculated over the trailing 6-month period | 17.34% | 14.01% | +3.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.36% | 22.49% | +3.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.84% | 24.30% | +3.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.46% | 23.40% | +5.06% |